Hruby received a number of academic awards for work in this area
For the past half-century, phentermine has been one of the most commonly prescribed weight loss drugs, and metformin has been one of the most popular diabetes medicationsand its also prescribed off-label for weight reduction
Furthermore, GLP-1 receptor agonists can reduce the risk of cardiovascular events by 20%
While both are effective, tirzepatide appears to offer more robust outcomes in terms of weight loss and glycaemic control, likely due to its dual mechanism
Clinical studies As summarized above, a multitude of preclinical studies have investigated the therapeutic effects of stimulating NAD + metabolism to ameliorate symptoms of aging and various pathologies, yielding promising results
Combinations should be clinician-directed